Performance of ADMA ADMA Biologics | 105.6% in 12m

Compare ADMA with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare ADMA Biologics with its related Sector/Index XBI

Compare ADMA Biologics with its related Sector/Index XBI

Performance Duell ADMA vs XBI

TimeFrame ADMA XBI
1 Day -2.08% -0.02%
1 Week 6.62% -0.33%
1 Month 22.7% -6.54%
3 Months 46.0% 4.44%
6 Months 86.4% 28.65%
12 Months 105.6% 27.48%
YTD 45.1% 5.16%
Rel. Perf. 1m 2.60
Rel. Perf. 3m 2.28
Rel. Perf. 6m 3.64
Rel. Perf. 12m 4.73

Is ADMA Biologics a good stock to buy?

Partly, yes. Based on ValueRay Fundamental Analyses, ADMA Biologics (NASDAQ:ADMA) is currently (March 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 3.98 and therefor a somewhat positive outlook according to fundamental data.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ADMA as of March 2024 is 6.60. This means that ADMA is currently overvalued and has a potential downside of 0%.

Is ADMA a buy, sell or hold?

  • Strong Buy: 3
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
ADMA Biologics has received a consensus analysts rating of 4.75. Therefor, it is recommend to buy ADMA.
Values above 0%: ADMA is performing better - Values below 0%: ADMA is underperforming

Compare ADMA with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 6.45% 19.04% 63.50% 71.47%
US NASDAQ 100 QQQ 7.04% 20.54% 61.94% 60.07%
US Dow Jones Industrial 30 DIA 6.62% 20.34% 67.17% 80.39%
German DAX 40 DBXD 4.85% 17.60% 65.86% 84.16%
UK FTSE 100 ISFU 5.86% 17.75% 76.27% 92.62%
Shanghai Shenzhen CSI 300 CSI 300 8.50% 20.86% 90.87% 121.30%
Hongkong Hang Seng HSI 10.16% 27.40% 92.54% 126.16%
Japan Nikkei 225 EXX7 7.16% 19.13% 64.58% 77.30%
India NIFTY 50 INDA 4.52% 21.64% 69.85% 71.01%
Brasil Bovespa EWZ 7.02% 25.47% 76.23% 76.68%

ADMA ADMA Biologics vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 6.61% 18.59% 61.96% 58.09%
Consumer Discretionary XLY 6.86% 22.07% 71.15% 74.83%
Consumer Staples XLP 6.16% 19.53% 74.13% 98.67%
Energy XLE 4.67% 11.65% 82.28% 84.69%
Financial XLF 6.09% 17.93% 59.54% 69.12%
Health Care XLV 5.18% 21.14% 71.63% 87.42%
Industrial XLI 6.37% 17.94% 61.79% 75.21%
Materials XLB 5.59% 15.40% 67.13% 83.68%
Real Estate XLRE 5.47% 20.11% 67.97% 89.53%
Technology XLK 7.37% 20.77% 58.46% 59.95%
Utilities XLU 3.67% 16.06% 72.87% 102.64%
Aerospace & Defense XAR 6.07% 20.02% 60.34% 82.27%
Biotech XBI 6.95% 29.22% 57.79% 78.13%
Homebuilder XHB 6.13% 13.38% 41.17% 34.29%
Retail XRT 5.53% 18.48% 54.88% 74.12%

ADMA ADMA Biologics vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 4.13% 15.74% 89.92% 83.64%
Natural Gas UNG 11.52% 35.59% 133.19% 152.28%
Gold GLD 4.76% 13.45% 67.68% 93.46%
Silver SLV 6.18% 11.97% 76.75% 99.45%
Copper CPER 7.72% 17.44% 76.79% 104.60%

Returns of ADMA vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 4.98% 21.19% 77.66% 111.82%
iShares High Yield Corp. Bond HYG 6.68% 21.98% 77.87% 93.23%
Does ADMA Biologics outperform its market, is ADMA a Sector Leader?
Yes, over the last 12 months ADMA Biologics (ADMA) made 105.61%, while its related Sector, the SPDR S&P Biotech (XBI) made 27.48%.
Over the last 3 months ADMA made 46.02%, while XBI made 4.44%.
Period ADMA XBI S&P 500
1 Month 22.68% -6.54% 3.64%
3 Months 46.02% 4.44% 10.07%
12 Months 105.61% 27.48% 34.14%